Drugs / ABX1100
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06109948 | Oct 2023 → Feb 2026 | glycogen storage disease due to acid maltase deficiency, late-onset | Aro Biotherapeutics | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABX1100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06109948 ↗ |